Giuseppe Toffoli

机构：Centro di Riferimento Oncologico, Istituti di Ricovero e Cura a Carattere Scientifico · ORCID：0000-0002-5323-4762

发表论文 457 篇 · 总被引 12757 次 · h-index 56

代表论文

• Clinical Benefits and Utility of Pretherapeutic DPYD and UGT1A1 Testing in Gastrointestinal Cancer (2024 · JAMA Network Open · 被引 24)
• Stealth-Engineered Albumin-Coated Nanoparticles for Targeted Therapy: Effective Drug Delivery and Tumor Suppression in Xenograft-Zebrafish Model (2024 · International Journal of Nanomedicine · 被引 18)
• CAR‐T Cell Manufacturing for Hematological and Solid Tumors: From the Preclinical to Clinical Point of View (2025 · Cancer Medicine · 被引 12)
• The anti-glypican 1 AT101 antibody as targeting agent to effectively deliver chitosan nanobubbles to glioblastoma cells (2024 · Nanomedicine · 被引 9)
• Gut Microbiota-Based Immunotherapy: Engineered Escherichia coli Nissle 1917 for Oral Delivery of Glypican-1 in Pancreatic Cancer (2025 · Medicina · 被引 8)
• Targeting Aging Hallmarks with Monoclonal Antibodies: A New Era in Cancer Immunotherapy and Geriatric Medicine (2025 · International Journal of Molecular Sciences · 被引 7)